ArticleOncology letters2023

Intermittent administration of atezolizumab with combined carboplatin and etoposide therapy for patients with extensive‑disease small cell lung cancer.

Takeshi Tsuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.